McKesson Corporation
Search results
Cencora’s depth and breadth of world-class human and animal health solutions is unrivaled. Our customers and partners — large and small, from pharmaceutical pioneers to care providers in settings around globe — have access to our groundbreaking tools and strategies to succeed in today’s healthcare market.
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001.
Cencora is a pharmaceutical solutions organization improving the lives of people and animals. Discover how we empower patient-centered care.
Since our founder’s apprenticeship in 1871, Cencora has become a leader in pharmaceutical solutions. Over our 150 years, we’ve continued to invest in our core pharmaceutical distribution business while expanding our pharma and biopharma services.
Cencora, a company building on the legacy of AmerisourceBergen, is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world.
Cencora enables our customers to bring their aspirations, innovations, and essential services to patients around the world. Wherever your business fits in the healthcare continuum, we have industry-leading solutions that accelerate better outcomes from concept to delivery.
Discover how Cencora transforms lives with innovative healthcare solutions, making a global impact for better patient outcomes.
Aug 30, 2023 · As a global healthcare company, Cencora will continue to invest in and focus on its core pharmaceutical distribution business, while also growing its platform of pharma and biopharma services to...
Aug 30, 2023 · New name of company reflects unified global presence and collective goal of creating healthier futures by accelerating positive outcomes for customers and their patients. Company announces more than $5 million commitment to global corporate philanthropic efforts.
May 28, 2024 · Almost a dozen pharmaceutical companies have lost sensitive customer data due to a supply chain cyberattack that trickled down from Cencora, TechRadar writes.
